Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Bruss N"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
CDK9 inhibition induces epigenetic reprogramming revealing strategies to circumvent resistance in lymphoma.
Autorzy:
Thieme E; City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.
Bruss N; City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.
Sun D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Division of Bioinformatics and Computational Biology, Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, USA.; Present address: School of Mathematics, Shandong University, Jinan, 250100, Shandong, China.
Dominguez EC; City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.
Coleman D; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
Liu T; City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.
Roleder C; City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.
Martinez M; Translational Genomics Research Institute, Phoenix, AZ, 85004, USA.; Integrated Mass Spectrometry Shared Resource, City of Hope National Medical Center, Duarte, CA, USA.
Garcia-Mansfield K; Translational Genomics Research Institute, Phoenix, AZ, 85004, USA.; Integrated Mass Spectrometry Shared Resource, City of Hope National Medical Center, Duarte, CA, USA.
Ball B; City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.
Pirrotte P; Translational Genomics Research Institute, Phoenix, AZ, 85004, USA.; Integrated Mass Spectrometry Shared Resource, City of Hope National Medical Center, Duarte, CA, USA.
Wang L; City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA.
Xia Z; Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.; Biomedical Engineering Department, Oregon Health & Science University, Portland, OR, USA.
Danilov AV; City of Hope National Medical Center, 1500 E Duarte Road, Duarte, CA, 91010, USA. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2023 Mar 30; Vol. 22 (1), pp. 64. Date of Electronic Publication: 2023 Mar 30.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Epigenesis, Genetic*
Lymphoma, Large B-Cell, Diffuse*/drug therapy
Lymphoma, Large B-Cell, Diffuse*/genetics
Cyclin-Dependent Kinase 9*/antagonists & inhibitors
Animals ; Mice ; Apoptosis ; Cell Line, Tumor ; Phosphatidylinositol 3-Kinases/metabolism ; Transcription Factors/genetics ; Drug Resistance, Neoplasm
Czasopismo naukowe
Tytuł:
Pharmacologic inhibition of the ubiquitin-activating enzyme induces ER stress and apoptosis in chronic lymphocytic leukemia and ibrutinib-resistant mantle cell lymphoma cells.
Autorzy:
Best S; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Liu T; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Bruss N; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Kittai A; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Berger A; Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA.
Danilov AV; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Dec; Vol. 60 (12), pp. 2946-2950. Date of Electronic Publication: 2019 May 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Resistance, Neoplasm*
Apoptosis/*drug effects
Endoplasmic Reticulum Stress/*drug effects
Leukemia, Lymphocytic, Chronic, B-Cell/*metabolism
Lymphoma, Mantle-Cell/*metabolism
Pyrazoles/*pharmacology
Pyrimidines/*pharmacology
Ubiquitin-Activating Enzymes/*metabolism
Adenine/analogs & derivatives ; Animals ; Biomarkers ; Cell Line, Tumor ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy ; Lymphoma, Mantle-Cell/diagnosis ; Lymphoma, Mantle-Cell/drug therapy ; Mice ; Piperidines ; Proteasome Inhibitors/pharmacology ; Proteasome Inhibitors/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Pyrazoles/therapeutic use ; Pyrimidines/therapeutic use ; Unfolded Protein Response/drug effects
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies